azathioprine has been researched along with Deafness, Sudden in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Deafness, Sudden: Complete sensorineural hearing loss which develops suddenly over a period of hours or a few days.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pyykkö, I | 1 |
| Ishizaki, H | 1 |
| Peltomaa, M | 1 |
1 trial available for azathioprine and Deafness, Sudden
| Article | Year |
|---|---|
Azathioprine with cortisone in treatment of hearing loss in only hearing ear.
Topics: Audiometry, Pure-Tone; Azathioprine; Cochlear Diseases; Deafness; Drug Therapy, Combination; Hearing | 1997 |